Skip to main content
SpringerLink
Log in

Mutant and hybrid protein derivatives for the experimental therapy with plasminogen activators (review)

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. “ISIS Steering committee (ISIS-2). Intravenous streptokinase given within 0–4 h of onset of myocardial infarction reduced mortality in ISIS-2,” Lancet, No. 8531, 502 (1987).

    Google Scholar 

  2. “Gruppo Italiano per lo studio della streptochinasi nell' infarto miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction,” Lancet, No. 8478, 397–401 (1986).

    Google Scholar 

  3. A. V. Maksimenko, Zh. Vses. Khim. D. I. Mendeleeva,32, 541–547 (1987).

    Google Scholar 

  4. A. V. Maksimenko, Methods of Chemical Modification in the Production of New Forms of Biologically Active Preparations (Itogi Nauki Tekhn. Ser. Biotekhnologiya) [in Russian], Vol. 8, Moscow (1988), pp. 50–78.

    Google Scholar 

  5. V. P. Torchilin, Advanc. Drug Deliv. Rev., Vol. 1 (1987) pp. 41–86.

    Google Scholar 

  6. D. Collen, Thrombos. Res., Suppl. 8, 3–14 (1988).

    Google Scholar 

  7. E. Haber, T. Quertermous, G. Matsueda, and M. Runge, Science,243, 51–56 (1989).

    Google Scholar 

  8. M. S. Runge, T. Quertermous, and E. Haber, Circulation,79, No. 2, 217–224 (1989).

    Google Scholar 

  9. D. Collen, H. R. Lijnen, and H. K. Gold, Progr. Cardiovasc. Dis.,34, No. 2, 101–112 (1991).

    Google Scholar 

  10. O. Nolan and R. O'Kennedy, Biochim. Biophys. Acta,1040, 1–11 (1990).

    Google Scholar 

  11. D. Collen, Blood Vessels,12, 502–508 (1981).

    Google Scholar 

  12. D. Pennica, W. E. Holmes, W. J. Kohr, et al., Nature,301, 214–221 (1983).

    Google Scholar 

  13. D. Collen, J. M. Stassen, B. J. Marafino Jr., et al., J. Biol. Chem.,231, No. 1, 146–152 (1984).

    Google Scholar 

  14. M. J. Browne, I. Dodd, J. E. Carey, et al., Thrombos. Haemostas.,54, No. 2, 422–424 (1985).

    Google Scholar 

  15. M. E. Winkler and M. Blader, Biochemistry,25, 4041–4045 (1986).

    Google Scholar 

  16. H. L. Heyneker, W. E. Holmes, and G. A. Vehar, Preparation of Functional Human Urokinase Proteins, Eur. Pat. Appl. 83103629.8. Publ. 0092182 A2.

  17. D. Collen, J. Am. Coll. Cardiol.,10, 11B-16B (1987).

    Google Scholar 

  18. K. Gordon, E. Lee, J. A. Vitale, et al., Biotechnology,5, No. 11, 1183–1187 (1987).

    Google Scholar 

  19. A. Upshall, A. A. Humar, M. C. Bailey, et al., Biotechnology,5, No. 12, 1301–1304 (1987).

    Google Scholar 

  20. A. Klausner, Biotechnology,5, No. 9, 896–870 (1987).

    Google Scholar 

  21. D. Lau, G. Kurzma, C.-M. Wei, et al., Ibid, 953–958.

    Google Scholar 

  22. B. Chaundhury, B. Meyhack, J. Heim, and J. van Oostrum, Modified Fibrinolytic Agents, Eur. Pat. 0225286 (1987).

  23. L. Nelles, H. R. Lijnen, D. Collen, and W. E. Holmes, J. Biol. Chem.,262, No. 12, 5682–5689 (1987).

    Google Scholar 

  24. G. F. Vovis and J.-I. Mao, Amino acid Modified Prourokinase and Method of Preparation, Eur. Pat. 0236040 (1987).

  25. H. R. Lijnen, L. Nelles, W. E. Holmes, and D. Collen, J. Biol. Chem.,263, 5594–5598 (1988).

    Google Scholar 

  26. H. R. Lijnen, B. van Hoff, and D. Collen, Eur. J. Biochem.,262, No. 24, 11771–11778 (1987).

    Google Scholar 

  27. L. Pierard, P. Jacobs, D. Gheysen, et al., J. Biol. Chem.,262, No. 24, 11771–11778 (1987).

    Google Scholar 

  28. T. Mikaye, Y. Hibino, Y. Kobayashi, et al., Stabilized Human Prourokinase (1986), PCT WO 86/04351.

  29. O. Freidman, Biotechnology,4, 258 (1986).

    Google Scholar 

  30. F. Van de Werf, J. Vanhaecke, H. De Geest, et al., Circulation,74, 1066–1070 (1986).

    Google Scholar 

  31. D. Eastman, F. M. Wurm, R. van Reis, and D. L. Higgins, Biochemistry,31, 419–422 (1992).

    Google Scholar 

  32. M. J. Browne, J. E. Carey, C. G. Chapman, et al., J. Biol. Chem.,263, No. 4, 1599–1602 (1988).

    Google Scholar 

  33. G. R. Larsen, M. Metzger, K. Henson, et al., Blood,73, No. 7, 1842–1850 (1989).

    Google Scholar 

  34. A. Hotchkiss, C. J. Refino, C. K. Leonard, et al., Thrombos. Haemostas.,60, No. 2, 255–261 (1988).

    Google Scholar 

  35. J. Kuiper, M. Offer, D. C. Rijken, and T. J. C. van Berkel, J. Biol. Chem.,263, No. 34, 18220–18224 (1988).

    Google Scholar 

  36. G. R. Larsen, G. A. Timony, P. G. Horgan, et al., J. Biol. Chem.,266, No. 13, 8156–8161 (1991).

    Google Scholar 

  37. L. Hansen, Y. Blue, K. Barone, et al., J. Biol. Chem.,263, No. 30, 15713–15719 (1988).

    Google Scholar 

  38. C. L. Lucore, S. Fujii, and B. E. Sobel, Circulation,29, 1204–1213 (1989).

    Google Scholar 

  39. A. J. Van Zonneveld, A.-J. Veerman, and H. Pannekoek, Proc. Natl. Acad. Sci. USA,83, 4670–4674 (1986).

    Google Scholar 

  40. P. J. Burk, D. H. Berg, M. W. Warrick, et al., J. Biol. Chem.,265, 5170–5177 (1990).

    Google Scholar 

  41. U. Kohnert, R. Rudolph, H. Prinz, et al., Fibrinolysis,4, Suppl. 3, Abstr. 116, 44 (1990).

    Google Scholar 

  42. C. V. Jackson, V. G. Crowe, T. J. Craft, et al., Circulation,82, 930–940 (1990).

    Google Scholar 

  43. C. V. Jackson, J. D. Frank, T. J. Craft, et al., J. Pharmacol. Exp. Ther.,260, 64–70 (1992).

    Google Scholar 

  44. K.-L. Neuhaus, W. Feuerer, S. Jeep-Tebbe, et al., J. Am. Coll. Cadiol.,14, No. 6, 1566–1569 (1989).

    Google Scholar 

  45. U. Martin, G. Sponer, and K. Strein, J. Am. Coll. Cardiol.,19, No. 2, 433–440 (1992).

    Google Scholar 

  46. D. Cheysen, H. R. Lijnen, L. Pierard, et al., J. Biol. Chem.,262, No. 24, 11779–11784 (1987).

    Google Scholar 

  47. L. Nolles, H. R. Lijnen, D. Collen, and W. E. Holmes, J. Biol. Chem.,262, No. 22, 10855–10862 (1987).

    Google Scholar 

  48. C. De Vries, H. Veerman, F. Blasi, and H. Pannekoek, Biochemistry,27, 2565–2572 (1988).

    Google Scholar 

  49. S. G. Lee, N. Kalyan, J. Wilhelm, et al., J. Biol. Chem.,263, No. 6, 2917–2924 (1988).

    Google Scholar 

  50. M. Tagawa, M. Wada, M. Yamada, et al., Hybrid Plasminogen Activator — Like Polypeptide, Eur. Pat. 0231883, (1987).

  51. J. J. Devlin, P. E. Devlin, R. Clark, et al., Biotechnology,7, 286–292 (1989).

    Google Scholar 

  52. J. M. Schnee, M. S. Runge, G. R. Matsueda, et al., Proc. Natl. Acad. Sci. USA,84, 6904–6908 (1987).

    Google Scholar 

  53. M. Dewerchin and D. Collen, Bioconjugate Chem.,2, No. 5, 293–300 (1991).

    Google Scholar 

  54. D. J. Hayzer, I. M. Lubin, and M. S. Runge, Bioconjugate Chem.,2, 301–308 (1991).

    Google Scholar 

  55. J. H. Robinson, M. J. Browne, J. E. Carey, et al., Circulation,86, 548–552 (1992).

    Google Scholar 

  56. H. R. Lijnen, L. Nelles, B. van Hoef, et al., J. Biol. Chem.,263, 19083–19091 (1988).

    Google Scholar 

  57. L. Nelles, H. R. Lijnen, A. van Nuffelen, et al., Thrombos. Haemostas.,64, 53–60 (1990).

    Google Scholar 

  58. H. R. Lu, H. R. Lijnen, J. M. Stassen, and D. Collen, Blood,78, No. 1, 125–131 (1991).

    Google Scholar 

  59. H. R. Lu, Z. Wu, P. Pauwels, et al., J. Am. Coll. Cardiol.,19, 1350–1359 (1992).

    Google Scholar 

  60. M. S. Runge, T. Quertermuos, P. J. Zavodny, et al., Proc. Natl. Acad. Sci. USA,88, 10337–10341 (1991).

    Google Scholar 

  61. B. Wiman and A. Hamsten, Seminars Thrombos. Hemostas.,16, No. 3, 207–216 (1990).

    Google Scholar 

  62. J. R. Charpie, M. S. Runge, G. R. Matsueda, and E. Haber, Biochemistry,29, 6374–6378 (1990).

    Google Scholar 

  63. D. V. Sakharov, V. V. Sinitsyn, G. A. Kratasjuk, et al., Thrombos. Res.,49, 481–488 (1988).

    Google Scholar 

  64. J. J. Carroll, Seminars Thrombos. Hemostas.,15, No. 3, 334–340 (1989).

    Google Scholar 

  65. C. Bode, M. S. Runge, E. E. Branscomb, et al., J. Biol. Chem.,264, No. 2, 944–948 (1989).

    Google Scholar 

  66. T. Kurokawa, S. Iwasa, and A. Kakinuma, Biotechnology,7, 1163–1167 (1989).

    Google Scholar 

  67. E. E. Branscom, M. S. Runge, C. E. Savard, et al., Thrombos. Haemostas.,64, 260–266 (1990).

    Google Scholar 

  68. J. W. Larrick, Pharmacol. Rev.,41, No. 4, 539–557 (1990).

    Google Scholar 

  69. J. D. Rodwell, Nature,342, 99–100 (1989).

    Google Scholar 

  70. P. Knight, Biotechnology,8, No. 2, 105–107 (1990).

    Google Scholar 

  71. M. Verstraete, J. Am. Coll. Cardiol.,10, 4B-10B (1987).

    Google Scholar 

  72. F. W. A. Verheugt, J. Cardiovasc. Pharmacol.,19, Suppl. 4, S1-S3 (1992).

    Google Scholar 

  73. D. J. Fitzgerald, M. Hanson, and G. A. Fitzgerald, J. Clin. Invest.,88, 1589–1595 (1991).

    Google Scholar 

  74. J. J. Popma, R. M. Calliff, S. G. Ellis, et al., J. Am. Coll. Cardiol.,20, 1305–1312 (1992).

    Google Scholar 

  75. L.-A. Levin and B. Jonsson, Eur. Heart J.,13, 2–8 (1992).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Experimental Cardiology, Cardiological Scientific Center, Russian Academy of Medical Sciences, Moscow

    A. V. Maksimenko

Authors
  1. A. V. Maksimenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 28, No. 5, pp. 4–11, May, 1994.

The given work was partly financed by means of the State Scientific Technical Program 08.05 “Newest Methods of Bioengineering,” the specialization “Engineering Enzymology,” and with the financial support of the Russian Academy of Medical Sciences.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maksimenko, A.V. Mutant and hybrid protein derivatives for the experimental therapy with plasminogen activators (review). Pharm Chem J 28, 293–302 (1994). https://doi.org/10.1007/BF02218422

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02218422

Keywords

Search

Navigation